August 18, 2020
The Ministry of Health, Labor and Welfare (MHLW) on August 17 granted orphan drug designation to seven APIs including Janssen Pharmaceutical’s ibrutinib. Ibrutinib was granted the status for expected indications of primary macroglobulinemia and lymphoplasmacytic lymphoma. The six other APIs...read more